acc01651 |
Nucleosome assembly protein 1-like 4 |
phosphorylation |
Ser125 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01652 |
AT-rich interactive domain-containing protein 3A |
phosphorylation |
Ser88 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01653 |
AT-rich interactive domain-containing protein 3A |
phosphorylation |
Ser119 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01654 |
BUD13 homolog |
phosphorylation |
Ser271 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01655 |
BUD13 homolog |
phosphorylation |
Ser325 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01656 |
Uncharacterized protein C7orf50 |
phosphorylation |
Ser59 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01657 |
G patch domain-containing protein 1 |
phosphorylation |
Ser6 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01658 |
G patch domain-containing protein 1 |
phosphorylation |
Ser8 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01659 |
Protein pelota homolog |
phosphorylation |
Ser381 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01660 |
Protein pelota homolog |
phosphorylation |
Ser382 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01661 |
Rhotekin |
phosphorylation |
Ser106 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01662 |
Death-inducer obliterator 1 |
phosphorylation |
Ser1456 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01663 |
Spindlin interactor and repressor of chromatin-binding protein |
phosphorylation |
Ser248 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01664 |
Telomerase Cajal body protein 1 |
phosphorylation |
Ser54 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01665 |
Kanadaptin |
phosphorylation |
Ser258 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01666 |
Serrate RNA effector molecule homolog |
phosphorylation |
Ser74 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01667 |
Tudor domain-containing protein 1 |
phosphorylation |
Ser462 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01668 |
GTP-binding protein 4 |
phosphorylation |
Ser470 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01669 |
182 kDa tankyrase-1-binding protein |
phosphorylation |
Ser1621 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01670 |
Probable ATP-dependent RNA helicase DDX47 |
phosphorylation |
Ser9 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01671 |
Probable E3 ubiquitin-protein ligase IRF2BPL |
phosphorylation |
Ser547 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01672 |
Protein unc-93 homolog B1 |
phosphorylation |
Ser547 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01673 |
Nuclear ubiquitous casein and cyclin-dependent kinase substrate 1 |
phosphorylation |
Ser214 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01674 |
Nuclear ubiquitous casein and cyclin-dependent kinase substrate 1 |
phosphorylation |
Ser204 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01675 |
Nuclear ubiquitous casein and cyclin-dependent kinase substrate 1 |
phosphorylation |
Ser229 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01676 |
Nuclear ubiquitous casein and cyclin-dependent kinase substrate 1 |
phosphorylation |
Ser234 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01677 |
Serine/threonine-protein kinase TAO3 |
phosphorylation |
Ser324 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01678 |
Pinin |
phosphorylation |
Ser100 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01679 |
ESF1 homolog |
phosphorylation |
Ser657 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01680 |
ESF1 homolog |
phosphorylation |
Ser77 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01681 |
ESF1 homolog |
phosphorylation |
Ser312 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01682 |
Pecanex-like protein 3 |
phosphorylation |
Ser425 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01683 |
Coiled-coil domain-containing protein 86 |
phosphorylation |
Ser18 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01684 |
Sin3 histone deacetylase corepressor complex component SDS3 |
phosphorylation |
Ser45 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01685 |
"Splicing factor, arginine/serine-rich 19" |
phosphorylation |
Ser874 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01686 |
"Splicing factor, arginine/serine-rich 19" |
phosphorylation |
Ser239 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01687 |
Ubiquitin-conjugating enzyme E2 Z |
phosphorylation |
Ser339 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01688 |
Sp110 nuclear body protein |
phosphorylation |
Ser244 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01689 |
Chromodomain-helicase-DNA-binding protein 8 |
phosphorylation |
Ser1424 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01690 |
GPN-loop GTPase 1 |
phosphorylation |
Ser338 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01691 |
Reticulon-4 |
phosphorylation |
Ser7 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01692 |
Inner centromere protein |
phosphorylation |
Ser831 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01693 |
Mitochondrial import receptor subunit TOM22 homolog |
phosphorylation |
Ser15 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01694 |
Sister chromatid cohesion protein PDS5 homolog B |
phosphorylation |
Ser1283 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01695 |
Alpha-parvin |
phosphorylation |
Ser14 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01696 |
G patch domain-containing protein 2 |
phosphorylation |
Ser117 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01697 |
WD repeat-containing protein 70 |
phosphorylation |
Ser638 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01698 |
Protein AATF |
phosphorylation |
Ser320 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01699 |
Bcl-2-associated transcription factor 1 |
phosphorylation |
Ser177 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01700 |
Bcl-2-associated transcription factor 1 |
phosphorylation |
Ser512 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|